SJIM
TMCI icon

St. Johns Investment Management’s Treace Medical Concepts TMCI Stock Holding History

St. Johns Investment Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-600
Closed -$9K – 182
2022
Q2 		$9K Hold
600
– – 0.01% 118
2022
Q1 		$11K Hold
600
– – 0.01% 126
2021
Q4 		$11K Hold
600
– – 0.01% 137
2021
Q3 		$16K Hold
600
– – 0.01% 114
2021
Q2 		$19K Buy
+600
New +$19.1K 0.01% 111

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

St. Johns Investment Management's TMCI Position: Q3 2022 in Review

St. Johns Investment Management sold out of Treace Medical Concepts (TMCI) in Q3 2022, closing a stake of 600 shares — an estimated $9K sold.

St. Johns Investment Management first reported a position in TMCI in Q2 2021 and held it in 5 quarters. The position peaked at $19K in Q2 2021. 91 funds tracked by Wall St. Rank hold TMCI as of Q3 2022.

  • St. Johns Investment Management reported no remaining Treace Medical Concepts position as of Q3 2022 after selling out during the quarter.
  • St. Johns Investment Management sold 600 Treace Medical Concepts shares in Q3 2022, an estimated $9K.
  • St. Johns Investment Management first reported a position in Treace Medical Concepts in Q2 2021 and held it in 5 quarters.
  • St. Johns Investment Management's Treace Medical Concepts position peaked at $19K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2022.

Based on St. Johns Investment Management's 13F filing for Q3 2022, filed 2 Nov 2022.